Grand Rounds: Omicron The Next Variant of Concern and Responses in the COVID Pandemic Efforts – Michigan State Medical Society

On Wednesday, January 26 from 12:00 12:45pm, Marty Soehnlen, PhD, MPH, PHLD(ABB), and Heather Blankenship, PhD, will provide a presentation on the Omicron variant's concerning rise in Michigan, how whole genome testing is performed, impacts upon diagnostic tests, current data trends, and impacts upon therapies.

Doctor Soehnlen is the Director of Infectious Disease at the Michigan Department of Health and Human Services, Bureau of Laboratories. She began her laboratory career at Ohio State University where she received a BS in Medical Technology followed by an MPH is Hospital and Molecular Epidemiology with a sub-specialization in public health genetics. Doctor Soehnlen went on to the Centers for Disease Control and Prevention as an APHL/CDC Class XII Emerging Infectious Diseases Fellow in the Rabies group before obtaining a PhD in Pathobiology from Penn State University. She spent 4 years in Landstuhl, Germany with the US Army Public Health Command Region in Europe. She also directs three local health department labs and one small commercial lab.

Doctor Blankenship is Section Manager of Bioinformatics and Sequencing at the Michigan Department of Health and Human Services, Bureau of Laboratories. She received her BS in Biology from George Mason University and her PhD from Michigan State University. She gained expertise for her career through study of human and prokaryotic genetics. Her post graduate studies focused on molecular genetics, epidemiology, biotechnology, and bioinformatics.

Approved for .75AMA PRA Category 1 Credit(s)

Please visit our website for more information or to register>>

See the original post here:
Grand Rounds: Omicron The Next Variant of Concern and Responses in the COVID Pandemic Efforts - Michigan State Medical Society